SciSparc Board of Directors to Promote Buyback Program of up to $1 Million
July 06, 2022 08:30 ET
|
SciSparc Ltd
TEL AVIV, Israel, July 06, 2022 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (the “Company” or “SciSparc”), a specialty, clinical-stage pharmaceutical company focusing on the development of...
SciSparc Successfully Completed The Development of its Proprietary Drug Candidate SCI-110 for its Upcoming Phase IIb Study In Tourette Syndrome
June 29, 2022 08:30 ET
|
SciSparc Ltd
TEL AVIV, Israel, June 29, 2022 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (the "Company" or "SciSparc"), a specialty, clinical-stage pharmaceutical company focusing on the development of...
3BC Solvent-Free CBN and Delta-8 - Leading the Way to Better Cannabinoids
May 11, 2022 11:00 ET
|
3BC, Inc
FARMINGTON, Conn., May 11, 2022 (GLOBE NEWSWIRE) -- 3BC is an industry leader and innovator in solvent-free cannabinoid distillation technology, helping manufacturers bring safe, clean, solvent-free...
Nexien BioPharma Engages Dr. Benedikt Schoser as Advisor
February 03, 2022 09:00 ET
|
Nexien BioPharma, Inc.
DENVER, Feb. 03, 2022 (GLOBE NEWSWIRE) -- Nexien BioPharma Inc. (OTCQB: NXEN) ("Nexien" or the "Company") today announced that it has retained Dr. Benedikt Schoser as an advisor to the Company. Dr....
Juva Life Advances JUVA-019 into Preclinical Development for Inflammatory Disease
January 06, 2022 04:00 ET
|
Juva Life Inc.
VANCOUVER, British Columbia, Jan. 06, 2022 (GLOBE NEWSWIRE) -- Juva Life Inc. (CSE: JUVA) (OTCQB: JUVAF) (FRANKFURT: 4VV) (“Juva Life,” “Juva” or the “Company”), a life sciences portfolio company...
Grapefruit USA, Inc. (OTCQB: GPFT) Leverages Its Patented Time Release Technology to Roll Out the World’s Most Effectively Bioavailable CBD Delivery Cream
December 06, 2021 06:00 ET
|
Grapefruit USA Inc.
LOS ANGELES and DESERT HOT SPRINGS, Calif., Dec. 06, 2021 (GLOBE NEWSWIRE) -- via InvestorWire – Grapefruit USA, Inc. (OTCQB: GPFT) (“Grapefruit” or the “Company”), a premiere California-based...
Juva Life Launches Preclinical Comparative Study to Evaluate Anti-Inflammatory Properties of Candidate JUVA-019 in Conjunction With Other Well-Known Cannabinoids
November 30, 2021 04:00 ET
|
Juva Life Inc.
VANCOUVER, British Columbia, Nov. 30, 2021 (GLOBE NEWSWIRE) -- Juva Life Inc. (CSE: JUVA) (OTCQB: JUVAF) (FRANKFURT: 4VV) (“Juva Life,” “Juva” or the “Company”), a life sciences portfolio company...
Red White & Bloom Florida Subsidiary Receives Cannabis Cultivation License at Apopka Greenhouse Site; Immediately Begins Grow Operations
October 12, 2021 07:00 ET
|
Red White & Bloom Brands Inc.
RWB launches Phase 1 of cultivation expansion in $1.3 Billion Florida market TORONTO and APOPKA, FL, Oct. 12, 2021 (GLOBE NEWSWIRE) -- Red White & Bloom Brands Inc. (CSE: RWB and OTC:...
FDA Grants Vitality Biopharma Orphan Drug Designation for VBX-100 Prodrug
August 10, 2021 09:00 ET
|
Vitality Biopharma, Inc
CLEVELAND, Aug. 10, 2021 (GLOBE NEWSWIRE) -- Vitality Biopharma, Inc. (OTC: VBIO) (“Vitality” or the “Company”), an innovation-driven drug development company dedicated to unlocking the therapeutic...
Vantage Hemp Co. Launches Bulk Formulation Services
July 29, 2021 06:30 ET
|
Vantage Hemp
Greeley, Colorado., July 29, 2021 (GLOBE NEWSWIRE) -- Vantage Hemp Co. today launched bulk formulations of its sought-after pharmaceutical-grade CBD products, to meet increasing demand worldwide....